مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,579
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

NITRAZEPAM VERSUS DIAZEPAM AS INTERMITTENT PROPHYLAXIS FOR FEBRILE SEIZURES

Pages

  10-16

Abstract

 Background and Objective: Benzodiazepines are used for prophylaxis of FEBRILE SEIZUREs. This study compares the effectiveness of intermittent NITRAZEPAM versus DIAZEPAM therapy in preventing the recurrence of FEBRILE SEIZUREs.Materials and Methods: This prospective randomized controlled trial was performed on neurologically normal children aged from 6 months to 3 years with a history of FEBRILE SEIZUREs without history of prescribed antiepileptic drugs and family history of epilepsy. The patients were randomly prescribed oral NITRAZEPAM (36 cases) or DIAZEPAM (37 cases) at the beginning of febrile disease. They were advised to use the medication within the first 48 hours of the onset of fever. All patients were followed for 9 months since the last seizure.Results: Recurrence of seizures occurred in 4 (10.8 %) patients of DIAZEPAM group, but it was not observed in any patients of the NITRAZEPAM group. Age, sex, weight, height, grade of fever at the beginning of FEBRILE SEIZURE, seizure duration and hemoglobin level did not reveal a significant difference between the two groups of patients, and likewise, these variables did not show any statistically significant difference among patients with or without recurrence.Conclusion: Intermittent NITRAZEPAM therapy for FEBRILE SEIZURE seems clinically advantageous in comparison to DIAZEPAM. To obtain more precise clinical and statistical results, further research is recommended.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    KAZEMI, A., BADV, R.SH., AHARCHI, B., & KAMALI, K.. (2014). NITRAZEPAM VERSUS DIAZEPAM AS INTERMITTENT PROPHYLAXIS FOR FEBRILE SEIZURES. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, 21(89), 10-16. SID. https://sid.ir/paper/61481/en

    Vancouver: Copy

    KAZEMI A., BADV R.SH., AHARCHI B., KAMALI K.. NITRAZEPAM VERSUS DIAZEPAM AS INTERMITTENT PROPHYLAXIS FOR FEBRILE SEIZURES. JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH[Internet]. 2014;21(89):10-16. Available from: https://sid.ir/paper/61481/en

    IEEE: Copy

    A. KAZEMI, R.SH. BADV, B. AHARCHI, and K. KAMALI, “NITRAZEPAM VERSUS DIAZEPAM AS INTERMITTENT PROPHYLAXIS FOR FEBRILE SEIZURES,” JOURNAL OF ADVANCES IN MEDICAL AND BIOMEDICAL RESEARCH, vol. 21, no. 89, pp. 10–16, 2014, [Online]. Available: https://sid.ir/paper/61481/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button